Abstract:INTRODUCTION:Hepatocellular carcinoma is currently the second leading cause of cancer-related deaths worldwide with an increasing incidence.OBJECTIVE:The objective of this study is to investigate the effect of vascular endothelial growth factor small interfering RNA (VEGF-siRNA) on rabbit VX2 carcinoma cell viability in vitro and the effect of transarterial embolization (TAE)-mediated VEGF-siRNA delivery on the growth of rabbit VX2 liver-transplanted model in vivo.METHODS:Quantitative reverse transcription polymerase chain reaction, enzyme-linked immunosorbent assay, and Western blot technologies were used to detect the expression level of VEGF. TAE and computed tomography scan were used to deliver the VEGF-siRNA and detect the tumor volume in vivo, respectively. Microvessel density was detected by immunohistochemistry with CD34 antibody. A biochemical autoanalyzer was used to evaluate the hepatic and renal toxicity.RESULTS:The designed VEGF-siRNAs could effectively decrease the expression levels of VEGF mRNA and protein in vitro and in vivo. In vitro, the viability of rabbit VX2 carcinoma cells was reduced by 38.5%±7.3% (VEGF-siRNA no 1) and 30.0%±5.8% (VEGF-siRNA no 3) at 48 hours after transfection. Moreover, in rabbit VX2 liver-transplanted model, the growth ratios of tumors at 28 days after TAE-mediated siRNA delivery were 155.18%±19.42% in the control group, 79.67%±19.63% in the low-dose group, and 36.09%±15.73% in the high-dose group, with significant differences among these three groups. Microvessel density dropped to 34.22±4.01 and 22.63±4.07 in the low-dose group and high-dose group, respectively, compared with the control group (57.88±5.67), with significant differences among these three groups. Furthermore, inoculation of VX2 tumor into the liver itself at later stage induced significant increase in alanine aminotransferase and aspartate aminotransferase, indicating an obvious damage of liver functions, while treatment of VX2 tumor via TAE-mediated VEGF-siRNA had no toxicity to the livers and kidneys of rabbits, and VEGF-siRNA had the ability to protect liver damage induced by tumor growth.CONCLUSION:This is the first study to demonstrate that targeting VEGF via TAE-mediated siRNA delivery may become a powerful new option for effective treatment of hepatocellular carcinoma in the clinic.

Combined therapy of radiofrequency ablation with transcatheter artery embolization in rabbit model of hepatic carcinoma

Abstract No. 334: Safety and Therapeutic Effect of RFA Combined with TAE in Rabbit VX2 Liver Tumors

Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer after Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model

The therapeutic effect of low frequency ultrasound mediated microbubbles destruction on rabbit VX2 orthotopic hepatic tumors

[Hepatic VX2 Tumor in Rabbits: Treated with Radio Frequency Ablation and Evaluated with Enhanced CT].

[Influence of As2O3-lipiodol Emulsion Via Transarterial Embolization on a VX2 Liver Tumor Model in Rabbits].

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Efficiently Inhibits Growth of VX2 Cells and VX2 Tumor Model of Hepatocellular Carcinoma in Rabbit by Transarterial Embolization-Mediated Sirna Delivery.

Effects of transcatheter arterial chemoembolization on growth and metastasis of rabbit VX2 hepatic tumor

The changes in blood supply and pathological findings in VX2 liver tumors of rabbits:before and after treated with transcatheter arterial embolization

[Transcatheter Arterial Chemoembolization with High-Dose Iodized Oil for Hepatic VX2 Tumor in Rabbits].

Assessment of Alternated Cooling and Heating Treatment by Us Combined Ceus in the Vx2 Rabbit Liver Tumor Model

Study on peritumoral anti-angiogenesis of hepatic VX2 tumor by transcatheter arterial chemoembolization combined with Sorafenib ultrasound microbubbles in rabbits

Image-Guided Radiofrequency Hyperthermia (Rfh)-Enhanced Direct Chemotherapy of Hepatic Tumors: the Underlying Biomolecular Mechanisms.

Efficacy and Safety of Percutaneous Microwave Coagulation Therapy Followed by 125I Seed Brachytherapy for VX2 Hepatic Tumors in a Rabbit Model

An Experimental Study of Different Interventional Methods on the VX-2 Tumor in the Rabbits Liver Bearing

Expression of VEGF and apoptosis of tumor cells in different regions of VX2 tumor in rabbit liver after radiofrequency ablation

Effect of Radiofrequency Ablation on T Lymphocyte Subsets in Peripheral Blood of Rabbits with Renal VX-2 Carcinoma

Angiogenesis in Residual Cancer and Roles of HIF-1α, VEGF, and MMP-9 in the Development of Residual Cancer after Radiofrequency Ablation and Surgical Resection in Rabbits with Liver Cancer.

Treatment of VX2 hepatic tumor in rabbits with radiofrequency ablation: a study of ghost cells in ablation zones

Targeting metabolic reprogramming promotes the efficacy of transarterial chemoembolization in the rabbit VX2 liver tumor model

Abstract No. 506 Image-guided Radiofrequency Hyperthermia-Enhanced Direct Chemotherapy of Hepatic Tumors: the Underlying Biomolecular Mechanisms